| Name | Title | Contact Details |
|---|
Telesta Therapeutics is a biopharmaceutical company focused on the development, manufacturing and commercialization of transformative human therapeutics. Our main focus is on novel medicines that address major unmet medical needs, particularly in oncology. Our anchor product, MCNA, has completed a Phase III pivotal study in patients with non-muscle invasive bladder cancer that have failed the first line therapy, bacillus Calmette-Guérin (BCG). Telesta submitted a Biologics Licensing Application (BLA) for MCNA with the U.S. FDA on June 29, 2015 and is seeking, upon marketing approval in the U.S., to make MCNA available for patients and their physicians. Our ultimate goal is to transform the treatment landscape and prolong and improve the lives of those affected by bladder cancer, one of the most common types of cancers today.
RAAS BLOOD PRODUCTS CO., LTD. is a Agoura Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Xymogen is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Biomedical Systems offers our Sponsors flexible and responsive customization to their unique protocol needs. We have the ability to leverage our company-wide offerings to enhance our Quality, Regulatory, Data Management, IT, and other support functions.
Angelus Plaza is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.